Propranolol and depression revisited: three cases and a review

Area of Science:

• Pharmacology
• Psychiatry
• Neuroscience

Background:

• Beta-adrenergic blocking agents, like propranolol, are widely used for various medical conditions.
• The potential for beta-blockade to influence mood and mental health remains a subject of ongoing research and debate.

Observation:

• Three distinct cases are presented where patients developed major depressive episodes.
• These depressive episodes met the diagnostic criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III).
• The onset of depression occurred subsequent to the administration of propranolol for pre-existing medical conditions.

Findings:

• The reported cases suggest a potential association between propranolol treatment and the development of major depressive episodes.
• The study highlights the need to consider psychiatric complications in patients undergoing beta-blocker therapy.

Implications:

• These findings warrant further investigation into the neurobiological mechanisms linking beta-adrenergic blockade to affective disorders.
• Clinicians should be vigilant in monitoring patients for mood changes during propranolol therapy.
• Understanding this relationship can inform safer prescribing practices and patient management strategies for beta-blocker medications.